Incannex Healthcare Income Statement (2020-2025) | IXHL

Income Statement Jun2020 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.07M0.01M-0.13M0.01M
Operating items
Research & Development 2.61M2.64M3.28M4.36M2.90M1.41M2.73M3.70M1.12M
Selling, General & Administrative 2.28M5.34M4.14M5.40M3.43M3.60M2.27M3.83M5.67M
Operating Expenses 4.89M7.98M7.42M9.76M6.33M5.02M5.00M7.53M6.79M
Operating Income -4.89M-7.98M-7.42M-9.74M-6.25M-5.00M-5.00M-7.53M-6.79M
EBIT -4.89M-7.98M-7.42M-9.74M-6.25M-5.00M-5.00M-7.53M-6.79M
Non-operating items
Interest & Investment Income 0.07M0.02M0.07M0.04M0.03M0.03M0.00M0.00M
Other Non Operating Income -0.00M-0.01M-0.01M-0.01M-0.01M-0.33M-0.99M-0.48M-0.01M
Non Operating Income 4.17M2.74M1.38M3.31M0.83M-0.89M1.03M-24.07M0.39M
Net income details
EBT -0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M
Profit After Tax -0.73M-5.24M-6.03M-6.46M-5.42M-5.89M-3.97M-31.60M-6.41M
Equity Income 0.01M
Income from Continuing Operations -0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M
Consolidated Net Income -0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M
Income towards Parent Company -0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M
Net Income towards Common Stockholders -0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M
Additional items
EPS (Basic) -0.08-0.33-0.38-0.39-0.29-0.33-0.20-0.51-0.02
EPS (Weighted Average and Diluted) -0.08-0.33-0.38-0.39-0.29-0.33-0.20-0.51-0.02
Shares Outstanding (Weighted Average) 12.09M15.87M15.87M15.87M15.87M17.64M17.64M17.86M29.43M347.71M
Shares Outstanding (Diluted Average) 15.87M15.87M15.87M16.16M17.64M17.62M19.63M34.45M310.31M
EBITDA -1.24M-4.31M-6.85M-6.13M-5.10M-6.31M-4.06M-31.25M-6.20M
Interest Expenses -0.03M0.17M0.13M-0.01M
Shares Outstanding 15.87M15.87M15.87M17.64M17.64M17.79M27.55M194.38M347.71M